Sobi Site 113 is a clinical research site located in Dallas, Texas, United States 75246.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Sobi Site 113 has participated in 1 clinical trials.
Therapeutic areas: Immune Thrombocytopenia.
Sponsors: Sobi, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sobi Site 113 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sobi Site 113 has 1 clinical trials on record. Their work covers Immune Thrombocytopenia.
Sobi Site 113 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.